Skip to Content

Nova Eye Medical Ltd ELXMF

Morningstar Rating
$0.10 −0.09 (46.24%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ELXMF is trading at a 823% premium.
Price
$0.10
Fair Value
$6.90
Uncertainty
Extreme
1-Star Price
$5.12
5-Star Price
$9.51
Economic Moat
Zfjl
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ELXMF is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.19
Day Range
$0.100.10
52-Week Range
$0.100.19
Bid/Ask
$0.00 / $0.10
Market Cap
$16.69 Mil
Volume/Avg
8,100 / 8,100

Key Statistics

Price/Earnings (Normalized)
Price/Sales
1.40
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Nova Eye Medical Ltd is a medical technology company that develops, manufactures and sells a portfolio of proprietary ophthalmic treatment technologies and devices. Used by eye surgeons globally, these technologies include iTrack minimally invasive glaucoma surgery (MIGS), a consumable surgical device that restores the eye's natural outflow pathway to lower pressure inside the eye and to eliminate patient reliance on anti-glaucoma medications for mild-moderate glaucoma. The company's operating segment include AlphaRET and Glaucoma Surgical Devices, it generates maximum revenue from Glaucoma Surgical Devices. Geographically, it derives a majority of revenue from the United States of America.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
301

Valuation

Metric
ELXMF
Price/Earnings (Normalized)
Price/Book Value
1.27
Price/Sales
1.40
Price/Cash Flow
Price/Earnings
ELXMF

Financial Strength

Metric
ELXMF
Quick Ratio
0.77
Current Ratio
1.47
Interest Coverage
−423.65
Quick Ratio
ELXMF

Profitability

Metric
ELXMF
Return on Assets (Normalized)
−30.83%
Return on Equity (Normalized)
−40.41%
Return on Invested Capital (Normalized)
−38.09%
Return on Assets
ELXMF
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesYplnxgjRyfczt$181.1 Bil
SYK
Stryker CorpZdcszvkdtBmzh$125.9 Bil
MDT
Medtronic PLCDrgmmygwGyymgm$113.1 Bil
BSX
Boston Scientific CorpZdvxyyqBpxszwr$111.2 Bil
EW
Edwards Lifesciences CorpGwfyvfyprQkkgpj$54.4 Bil
DXCM
DexCom IncWtydjbrxtClmm$51.8 Bil
PHG
Koninklijke Philips NV ADRZdslrjnjFgbvzwv$25.9 Bil
ZBH
Zimmer Biomet Holdings IncBkgfpbdyMknt$24.5 Bil
ALGN
Align Technology IncXlnzgfnwBxrkjgt$19.9 Bil
PODD
Insulet CorpMdptszgsvXtksy$12.9 Bil

Sponsor Center